The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The FDA is warning patients and doctors about a new risk associated with Strattera. Strattera is used to treat a condition called Attention-Deficit with Hyperactivity Disorder (ADHD) in children, teens, and adults. Suicidal thoughts or actions: Strattera may increase thoughts of suicide or suicide attempts in infrequent cases. Call you doctor right away if you become irritable or anxious or have other mood changes, or if you have thoughts of suicide.

The FDA is warning patients and doctors about a new risk associated with Strattera. The Patient Information Sheet posted by the FDA regarding Atomoxetine (marketed as Strattera) contains the following information. Strattera is used to treat a condition called Attention-Deficit with Hyperactivity Disorder (ADHD) in children, teens, and adults. Suicidal thoughts or actions: Strattera may increase thoughts of suicide or suicide attempts in infrequent cases. Call you doctor right away if you become irritable or anxious or have other mood changes, or if you have thoughts of suicide. [Just how this instuction will be applied by children or teenagers is left to our imagination.]

Strattera has not been studied in children under 6 years old.

Comments are closed.

Of Interest